A novel fusion gene, TRIM5-cyclophilin a in the pig-tailed macaque determines its susceptibility to HIV-1 infection

AIDS

Volumn 21, Issue SUPPL. 8, 2007, Pages

  Liao, Cheng Hong ^a,b   Kuang, Yi Qun ^a,b   Liu, Hong Liang ^a,b   Zheng, Yong Tang ^a   Su, Bing ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cyclophilin A; Fusion gene; HIV 1 restriction factor; Pig tailed macaque; TRIM5

Indexed keywords

CYCLOPHILIN A; ISOPROTEIN; PROTEIN TRIMCYP; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

AOTUS; ARTICLE; CERCOPITHECIDAE; EXPRESSION VECTOR; FUSION GENE; GENE; GENE EXPRESSION REGULATION; GENE FUSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MACACA; MNTRIMCYP GENE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PIG TAILED MACAQUE; PRIORITY JOURNAL; SPECIES DIFFERENCE; TRIM5ALPHA GENE; VIRUS ENTRY; VIRUS INHIBITION; VIRUS TYPING; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; AOTIDAE; BASE SEQUENCE; DISEASE SUSCEPTIBILITY; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; MACACA NEMESTRINA; MOLECULAR SEQUENCE DATA; MONKEY DISEASES; MUTAGENESIS, INSERTIONAL; MUTANT CHIMERIC PROTEINS; RETROELEMENTS; SPECIES SPECIFICITY; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 37549007550     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000304692.09143.1b     Document Type: Article

References (33)

1. Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, et al. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 1987; 28:543-547.
2. Franchini G, Bosch ML. Genetic relatedness of the human immunodeficiency viruses type 1 and 2 (HIV-1, HIV-2) and the simian immunodeficiency virus (SIV). Ann N Y Acad Sci 1989; 554:81-87.
3. Fultz PN, McClure HM, Swenson RB, McGrath CR, Brodie A, Getchell JP, et al. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol 1986; 58:116-124.
4. Lusso P, Markham PD, Ranki A, Earl P, Moss B, Dorner F, et al. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. J Immunol 1988; 141:2467-2473.
5. Agy MB, Frumkin LR, Corey L, Coombs RW, Wolinsky SM, Koehler J, et al. Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 1992; 257:103-106.
6. Kent SJ, Corey L, Agy MB, Morton WR, McElrath MJ, Greenberg PD. Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. J Clin Invest 1995; 95:248-256.
7. Pekrun K, Shibata R, Igarashi T, Reed M, Sheppard L, Patten PA, et al. Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling. J Virol 2002; 76:2924-2935.
8. Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 2002; 297:1703-1706.
9. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 2003; 22:385-394.
10. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418:646-650.
11. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427:848-853.
12. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, Scammell J, et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999; 73:10020-10028.
13. Nisole S, Lynch C, Stoye JP, Yap MW. A TRIM5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 2004; 101:13324-13328.
14. Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004; 430:569-573.
15. Johnson VA, Byington RE. Infectivity assays (virus field assay). In: Aldovini A, Walker BD, editors. Techniques in HIV research. New York: Stockton Press; 1990. pp. 71-76.
16. Ouyang DY, Chan H, Wang YY, Huang H, Tam SC, Zheng YT. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin. Biochem Biophys Res Commun 2006; 339:25-29.
17. Liu HL, Wang YQ, Liao CH, Kuang YQ, Zheng YT, Su B. Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection. Gene 2005; 362 C:109-116.
18. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 2005; 102:2832-2837.
19. Yap MW, Nisole S, Stoye JP. A single amino acid change in the SPRY domain of human TRIM5alpha leads to HIV-1 restriction. Curr Biol 2005; 15:73-78.
20. Franke EK, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996; 222:279-282.
21. Karpas A, Lowdell M, Jacobson SK, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Natl Acad Sci U S A 1992; 89:8351-8355.
22. Javanbakht H, Diaz-Griffero F, Stremlau M, Si Z, Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J Biol Chem 2005; 280:26933-26940.
23. Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 2005; 79:15567-15572.
24. Franke EK, Yuan HE, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994; 372:359-362.
25. Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol 2005; 79:176-183.
26. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994; 372:363-365.
27. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003; 9:1138-1143.
28. Zhang Z, Harrison PM, Liu Y, Gerstein M. Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome. Genome Res 2003; 13:2541-2558.
29. Berthoux L, Sebastian S, Sokolskaja E, Luban J. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci U S A 2005; 102:14849-14853.
30. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, et al. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996; 87:1285-1294.
31. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A 2003; 100:1298-1303.
32. Otten RA, Smith DK, Adams DR, Pullium JK, Jackson E, Kim CN, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (Human Immunodeficiency Virus Type 2). J Virol 2000; 74:9771-9775.
33. 89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission. J Infect Dis 2001; 183:1023-1030.